Incidence of new-onset diabetes mellitus among patients receiving atypical neuroleptics in the treatment of mental illness: evidence from a privately insured population. [electronic resource]
Producer: 20050630Description: 387-95 p. digitalISSN:- 0022-3018
- Adult
- Antipsychotic Agents -- adverse effects
- Benzodiazepines -- adverse effects
- Clozapine -- adverse effects
- Diabetes Mellitus -- chemically induced
- Dibenzothiazepines -- adverse effects
- Female
- Follow-Up Studies
- Humans
- Incidence
- Insurance Coverage -- statistics & numerical data
- Male
- Mental Disorders -- drug therapy
- Olanzapine
- Proportional Hazards Models
- Quetiapine Fumarate
- Risk Factors
- Risperidone -- adverse effects
- Sex Factors
- United States -- epidemiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.